RIC followed by allogeneic stem-cell transplantation is feasible, has a low treatment-related mortality, and seems to be a promising salvage treatment for relapsed PTCL. These findings suggest that the existence of a graft-versus-T-cell lymphoma effect

Graft-Versus-Lymphoma Effect in Relapsed Peripheral T-Cell Non-Hodgkin's Lymphomas After Reduced-Intensity Conditioning Followed by Allogeneic Transplantation of Hematopoietic Cells / Corradini, P; Dodero, A; Zallio, F; Caracciolo, D; Casini, M; Bregni, M; Narni, Franco; Patriarca, F; Boccadoro, M; Benedetti, F; Rambaldi, A; Gianni, Am; Tarella, C.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - STAMPA. - 22:(2004), pp. 2172-2176.

Graft-Versus-Lymphoma Effect in Relapsed Peripheral T-Cell Non-Hodgkin's Lymphomas After Reduced-Intensity Conditioning Followed by Allogeneic Transplantation of Hematopoietic Cells.

NARNI, Franco;
2004-01-01

Abstract

RIC followed by allogeneic stem-cell transplantation is feasible, has a low treatment-related mortality, and seems to be a promising salvage treatment for relapsed PTCL. These findings suggest that the existence of a graft-versus-T-cell lymphoma effect
22
2172
2176
Graft-Versus-Lymphoma Effect in Relapsed Peripheral T-Cell Non-Hodgkin's Lymphomas After Reduced-Intensity Conditioning Followed by Allogeneic Transplantation of Hematopoietic Cells / Corradini, P; Dodero, A; Zallio, F; Caracciolo, D; Casini, M; Bregni, M; Narni, Franco; Patriarca, F; Boccadoro, M; Benedetti, F; Rambaldi, A; Gianni, Am; Tarella, C.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - STAMPA. - 22:(2004), pp. 2172-2176.
Corradini, P; Dodero, A; Zallio, F; Caracciolo, D; Casini, M; Bregni, M; Narni, Franco; Patriarca, F; Boccadoro, M; Benedetti, F; Rambaldi, A; Gianni, Am; Tarella, C.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/456116
Citazioni
  • ???jsp.display-item.citation.pmc??? 53
  • Scopus 261
  • ???jsp.display-item.citation.isi??? 218
social impact